Meeting
2018 Palliative and Supportive Care in Oncology Symposium
Incidence of skeletal-related events in men with castration-resistant prostate cancer.
Authors
Alison Tse Kawai
RTI Health Solutions, Waltham, MA
Alison Tse Kawai, David Martinez, Catherine W. Saltus, Zdravko Vassilev, Montse Soriano-Gabarro, James A. Kaye
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Advance Care Planning; Caregiver Support; Coordination and Continuity of Care; End-of-Life Care; Models of Care; Survivorship; and Symptom Biology, Assessment and Management
Track
Advance Care Planning,End-of-Life Care,Survivorship,Coordination and Continuity of Care,Symptom Biology, Assessment, and Management,Models of Care,Caregiver Support
Sub Track
Symptom Biology, Assessment, and Management
Citation
J Clin Oncol 36, 2018 (suppl 34; abstr 188)
DOI
10.1200/JCO.2018.36.34_suppl.188
Abstract #
188
Poster Bd #
E6
Abstract Disclosures
Similar Posters
Poster
2017 Genitourinary Cancers Symposium
Evaluation of treatment patterns and costs for patients with prostate cancer and bone metastases.
First Author: Adriana Valdarrama
Poster
2023 ASCO Annual Meeting
Comparative real-world (RW) evidence on darolutamide (Daro), enzalutamide (Enza), and apalutamide (Apa) for patients (Pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC) in the United States: DEAR.
First Author: Alicia K. Morgans
Poster
2023 ASCO Genitourinary Cancers Symposium
Racial differences in survival and healthcare resource utilization among Medicaid-insured adults with metastatic castration-resistant prostate cancer.
First Author: Maral DerSarkissian
Poster
2022 ASCO Genitourinary Cancers Symposium
Real-world treatment patterns among patients with metastatic castration-resistant prostate cancer (mCRPC) in the US.
First Author: Elisabetta Malangone-Monaco